Smith & Nephew plc (NYSE:SNN) has received an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company.

Several brokerages recently weighed in on SNN. Zacks Investment Research downgraded shares of Smith & Nephew from a “hold” rating to a “sell” rating in a research note on Wednesday, June 13th. UBS Group raised shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research note on Wednesday, April 18th. Deutsche Bank downgraded shares of Smith & Nephew from a “hold” rating to a “sell” rating in a research note on Thursday, May 3rd. Finally, HSBC raised shares of Smith & Nephew from a “hold” rating to a “buy” rating in a research note on Monday, March 26th.

Shares of Smith & Nephew traded up $0.12, hitting $35.71, on Friday, Marketbeat reports. The company’s stock had a trading volume of 348,200 shares, compared to its average volume of 748,968. Smith & Nephew has a 52-week low of $33.72 and a 52-week high of $40.43. The company has a quick ratio of 1.06, a current ratio of 2.03 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $15.48 billion, a PE ratio of 18.78, a P/E/G ratio of 2.03 and a beta of 0.58.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Sei Investments Co. increased its position in Smith & Nephew by 1.8% during the 4th quarter. Sei Investments Co. now owns 131,946 shares of the medical equipment provider’s stock worth $4,619,000 after purchasing an additional 2,371 shares in the last quarter. Icon Wealth Partners LLC acquired a new stake in Smith & Nephew during the 4th quarter worth approximately $120,000. Millennium Management LLC increased its position in Smith & Nephew by 24.0% during the 4th quarter. Millennium Management LLC now owns 1,350,040 shares of the medical equipment provider’s stock worth $47,265,000 after purchasing an additional 261,072 shares in the last quarter. Deutsche Bank AG increased its position in Smith & Nephew by 13,043.0% during the 4th quarter. Deutsche Bank AG now owns 241,568 shares of the medical equipment provider’s stock worth $8,457,000 after purchasing an additional 239,730 shares in the last quarter. Finally, First Trust Advisors LP increased its position in Smith & Nephew by 34.2% during the 4th quarter. First Trust Advisors LP now owns 12,790 shares of the medical equipment provider’s stock worth $448,000 after purchasing an additional 3,260 shares in the last quarter. 8.51% of the stock is owned by institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.